Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 8
Submit an article Journal homepage
748
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

Uwe ZeymerInstitut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany;Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, GermanyCorrespondenceUwe.Zeymert-online.de
,
Claus JüngerInstitut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany
,
Ralf ZahnHerzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
,
Timm BauerHerzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
,
Kurt BestehornMSD, Haar, Germany
,
Jochen SengesHerzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
&
Anselm GittInstitut für Herzinfarktforschung Ludwigshafen an der Universität Heidelberg, Germany;Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
 show all
Pages 1563-1570 | Accepted 22 May 2011, Published online: 17 Jun 2011

References

  • Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660
  • Anderson JL, Adams CD, Antman EM, et al. ACC/AHA guidelines for the patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 2007;116:e148-e304
  • Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008;29:2909-45
  • Kushner F, Hand M, Smith S, et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update). J Am Coll Cardiol 2009;54:2205-41
  • Rottlaender D, Scherner M, Schneider T, et al. Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany. Dtsch Med Wschr 2007;132:139-44
  • Bosworth HB. Medication treatment adherence. In: Bosworth, et al. (eds) Patient Treatment Adherence. New York: Routledge 2003;147-90
  • Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-24
  • The Indian Polycap Study. Effects of a polypill on risk factors in middle-aged individuals without cardiovascular disease: a phase II, double-blind randomized trial. Lancet 2009;373:1341-51
  • Antithrombotic trialists’ collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ 2002;324:71-86
  • ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Circulation 1998;97:2202-12
  • Cholesterol treatment trialists’ collaborators. Efficacy and safety of cholesterol-lowering treatment: a prospective meta-analysis of data from 90,056 patients in 14 randomised trials with statins. Lancet 2005;366:1267-78
  • Zeymer U, Gitt AK, Jünger C, et al. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice. Eur Heart J 2006;27:2661-6
  • Montalescot G, Dallongeville J, van Belle E, et al. STEMI and NSTEMI: are they so different: 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition. Eur Heart J 2007;28:1409-17
  • Fonarow C, French WJ, Frederick PD. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006. Am Heart J 2009;157:185-94
  • Rosengren A, Wallentin L, Simoons M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006;27:789-95
  • Sanz G, Fuster V. Fixed dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population. Nature Clin Pract Cardiovasc Med 2009;6:101-10
  • Fuster V. Prime time for a polypill after myocardial infarction. Nature Clin Pract Cardiovasc Med 2009;6:83
  • Danchin N, Cambou J, Hanania G, et al. Impact of combined secondary prevention after myocardial infarction. Data from a nationwide French registry. Am Heart J 2005;150:1147-53
  • Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Effects of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease. J Hum Hypertens 2004;18:781-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.